NIX-0699

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNIX-0699
Drug Alias NameNiprisanHemoxinNicosanNIX-0699
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionCytochrome P450 3A4 inhibitors
TargetsCytochrome P450 3A4
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsAnemia, Sickle Cell
Approved Indications in ChinaN/A
Original Approved Country/TerritoryNigeria
Original Approved Date2006/07/06
Country/TerritoryNigeria
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNational Institute For Pharmaceutical Research And Development
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute For Pharmaceutical Research And DevelopmentXechem International
Inactive CompaniesN/A
Active IndicationsAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeB03XA
Related LinksWikipedia